Department of Neurology Grand Rounds

All Presentations Are Held in K-307 (3-6408)
9:00 – 10:30 AM

Upcoming 2015 2014 2013

Date Title/Presenter/Affiliation
Feb 22 Will Public Reporting of Stroke Outcome Measures Improve Quality of Care?
James F. Burke, M.D.
Department of Neurology, University of Michigan Health System, Center for Clinical Management & Research, Ann Arbor VA
Mar 01 Pathophysiology of Psychogenic Movement Disorders
Mark Hallett, M.D.
Chief of Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institute of Health
Mar 08 Duchenne Muscular Dystrophy: Standard of Care and Emerging Therapeutic Strategies. How are we doing?
Emma Ciafaloni, M.D.
Associate Professor, Departments of Neurology & Pediatrics, University of Rochester Medical Center
Mar 15 TBD
Michel J. Berg, M.D.
Associate Professor, Department of Neurology, University of Rochester Medical Center
Mar 29 Optimal Treatment of Intracranial Atherosclerosis
Marc I. Chimowitz, M.B.Ch.B.
Professor of Neurology, Associate Dean of Faculty Development, Department of Neurosciences, Medical University of South Carolina
Apr 05 Prion Mechanisms in Tauopathy: New Opportunities for Therapy
Marc I. Diamond, M.D.
David Clayson Endowed Professor of Neurology, Adult Neurology Division, Department of Neurology, Washington University School of Medicine–St. Louis
Apr 12 Imaging Brain Networks in Hyperkinetic Movement Disorders
Andrew S. Feigin, M.D.
Professor of Molecular Medicine & Neurology, Director, Experimental Therapeutics Unit, Susan and Leonard Feinstein Center for Neurosciences, Associate Director, General Clinical Research Center, Department of Neurology, North Shore University Hospital
Apr 19 TBD
Valerie Askanas, M.D., Ph.D.
Professor of Neurology
Apr 26 Patient-Centered Care
Todd M. Holmquist, M.D.
Assistant Professor of Neurology, Medical Director, 5-1600 Unit, University of Rochester Medical Center
Apr 26 Patient-Centered Care
Shayne M. Hawkins, R.N.
Nurse Manager, 5-1600 Unit, Department of Neurology, University of Rochester Medical Center
May 03 Health Care Reform: Accountable Health Partners
Robert McCann, MD, FACP
Chief and Professor of Medicine, Department of Medicine, Highland Hospital
May 10 Premotor PD. What does that mean
Tanya Simuni, M.D.
Arthur C. Nielsen Professor of Neurology, Director, Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine
May 17 Lundbeck- Focused on CNS
Ulf Wiinberg
Chief Executive Officer, Lundbeck Pharmaceuticals
May 24 Optical Coherence Tomography: Keeping an eye on the axons in Multiple Sclerosis
Peter Calabresi, M.D.
Professor of Neurology, Director, The Johns Hopkins Multiple Sclerosis Center, Director, Division of Neuroimmunology & Neuroinfectious Diseases, Department of Neurology, The Johns Hopkins Hospital
May 31 The Future of Neuromedicine in an Era of the Accountable Care Act: How Can Specialists Adapt to Pay-for-Performance and Population Management
Steven Toms, M.D.
Director of Neurosurgery, Department of Neurosurgery, Geisinger Medical Center
Jun 07 Setting Priorities for Stroke Care and Research
Lewis Morgenstern, M.D.
Professor of Neurology, Director of Stroke Program, Department of Neurology University of Michigan Health System
Jun 14 CNS Lymphoma
Tracy Batchelor, M.D., MPH
Executive Director, Stephen & Catherine Pappas Ctr. for Neuro-Oncology, Director, Division of Neuro-Oncology, Department of Neurology, Professor of Neurology, Harvard Medical School
Jun 21 Clinical Trials of Cell Therapy for Stroke
Lawrence Wechsler, M.D.
Henry B. Higman Professor of Neurology/Neurosurgery and Chair, Department of Neurology; Vice President, Telemedicine, Physician Services Division
Jun 28 Surgical Treatment for Lumbar Spinal Stenosis
William C. Welch, MD, FAANS, FACS, FICS
Chief, Department of Neurosurgery The Pennsylvania Hospital, Professor, Neurological Surgery, Vice Chairman for Clinical Affairs, Department of Neurosurgery
Jun 28 Medical Therapy for Neurogenic Claudication: The Current Evidence and a Research Agenda
John D. Markman, MD
Director, Neuromedicine Pain Management Center
Jul 12 Endovascular Therapy for Stroke
Babak S. Jahromi, M.D., Ph.D.
Surgical Director, URMC Stroke and Cerebrovascular Center
Jul 12 TBD
Curtis Benesch, M.D., M.P.H.
Associate Professor & Associate Chair for Clinical Affairs of Neurology
Jul 19 Headache: Unlocking the Mystery
Catherine Lavigne, M.D., Heidi B. Schwarz, M.D.
Clinical Associate Professors, Department of Neurology
Jul 26 Dementia Update
Frederick J. Marshall, M.D.
Associate Professor, Department of Neurology
Aug 02 Reproductive Issues In People With Epilepsy
Lynn C. Liu, M.D.
Associate Professor, Department of Neurology, Epilepsy
Aug 09 Neuroimmunology Update 2013: Inpatient Management Issues
Andrew Goodman, M.D.
Chief, Neuroimmunology Unit; Professor, Department of Neurology
Sep 06 State of the Department
Robert Holloway, M.D., M.P.H.
Chair, Department of Neurology, URMC
Sep 13 Genetics of Epilepsy: “New” Mutations for Pediatric Epilepsies
Annapurna Poduri, M.D., M.P.H.
Director, Epilepsy Genetics Program, Co-Director, Program in Neurogenetics, Assistant Professor of Neurology (Child Neurology), Harvard Medical School
Sep 20 Pre-clinical Development of Disease Modifying Therapy for Epilepsy
Amy Brooks-Kayal, M.D.
Professor of Pediatrics and Neurology, Section Head, Child Neurology, Chief and Ponzio Family Chair in Pediatric Neurology, University of Colorado
Sep 27 Gaining Ground in Research to Improve Neurologic Care and Outcomes
Barbara Vickrey, M.D., M.P.H.
Vice Chair, Academic Affairs, Neurology, Professor, Semel Institute for Neuroscience and Human Behavior, UCLA
Oct 04 Ketogenic Diets: More Fat for Fewer Seizures
Eric Kossoff, M.D.
Associate Professor, Neurology and Pediatrics, Johns Hopkins
Oct 11 From Bladder-to-Bowel-to-Brain: The Path of Parkinson Disease
Robert Hamill, M.D.
Neurologist, Fletcher Allen, Professor, University of Vermont College of Medicine
Oct 18 Treating Disease Before Illness – 21st Century Clinical Trials
Karl Kieburtz, M.D., M.P.H.
Director, Center for Human Experimental Therapeutics (CHET), URMC , Robert Joynt Professor of Neurology, URMC
Oct 25 Neurologic Research Priorities Where There is No Neurologist or Neurology on the Road Less Traveled
Gretchen Birbeck, M.D., M.P.H.
Professor, Neurology, Epilepsy, Center for Human Experimental Therapeutics
Nov 01 Advocacy for Rare Diseases
Frank J. Sasinowski, M.S., M.P.H., J.D.
Director at Hyman, Phelps & McNamara, P.C.
Nov 08 Neurofibromatosis Type 1: From Diagnosis to Personalized Treatments
David H. Gutmann, M.D., Ph.D.
Donald O. Schnuck Family Professor of Neurology, Director of the Washington University Neurofibromatosis (NF) Center; Co-director of the Neuro-Oncology Program in the Washington University/Alvin J. Siteman Cancer Center
Nov 15 New Golden Era of Medicine
E. Ray Dorsey, M.D., M.B.A.
Professor of Neurology; Department of Neurology, Center for Human Experimental Therapeutics (CHET)
Dec 06 'Seeing' Patients: Cultural Awareness in Academic Medicine and Why We Need it
Emma Ciafaloni, M.D.
Associate Professor, Neurology & Pediatrics, Department of Neurology, University of Rochester
Dec 13 How to Build a Better Neurologist
Charles Flippen II, M.D.
Professor of Neurology; Director, Residency Training Program, Department of Neurology, UCLA Headache Research and Treatment Program, David Geffen School of Medicine at UCLA
Dec 20 Personality and Multiple Sclerosis: New Questions, New Findings
Paul Duberstein, Ph.D. & Ralph Benedict, Ph.D.
Professor, Psychiatry, Psychology, & Family Medicine, University of Rochester Medical Center